Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing "By delivering rapid, ...

MeMed, a leader in host-response diagnostics, announced today that several oral presentations at the upcoming American College of Emergency Physicians (ACEP) Scientific Assembly 2025 will showcase the ...

– Milestone Achieved Through Growing Clinical Evidence Demonstrating Real-World Impact on Infection Management – – MeMed and Physicians Premier Celebrated Milestone Event in Corpus Christi, Texas – ...

Beckman Coulter Diagnostics, a Danaher company and global leader in clinical diagnostics, today announced it has received CE 2797 mark under IVDR for the Access MeMed BV assay, enabling broad ...